ENDRA Life Sciences (NDRA) Q2 2026 Earnings Report

861 Followers

NDRA Q2 2026 EPS Results

Actual EPS$0.12

Consensus EPS-$0.84

Beat/MissBeat by +$0.96

One Year Ago EPS-$1.71

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2026

Date08/17/2026

TimeBefore Open

Conference CallMonday, August 17, 2026

NDRA Upcoming Earnings

ENDRA Life Sciences's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 16, 2026	2026 (Q3)	-0.84 / -	-2.1	―
Aug 17, 2026	2026 (Q2)	-0.84 / 0.12	-1.71	107.08% (+1.83)
May 18, 2026	2026 (Q1)	- / -1.09	-1.86	41.40% (+0.77)
Mar 31, 2026	2025 (Q4)	-1.23 / -1.09	-1.86	41.40% (+0.77)
Nov 17, 2025	2025 (Q3)	-1.95 / -2.10	-9.54	77.99% (+7.44)
Jun 30, 2025	2025 (Q2)	-2.27 / -1.71	-140	98.78% (+138.29)
May 15, 2025	2025 (Q1)	- / -1.86	-455	99.59% (+453.14)
Mar 31, 2025	2024 (Q4)	-3.91 / -1.86	-455	99.59% (+453.14)
Nov 15, 2024	2024 (Q3)	-62.30 / -9.54	-700	98.64% (+690.46)
Aug 22, 2024	2024 (Q2)	-122.50 / -140.00	-752.5	81.40% (+612.50)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed